Skip to main content

Advertisement

SpringerLink
Log in

Clinical recovery and health-related quality of life in ischaemic stroke survivors receiving thrombolytic treatment: a 1-year follow-up study

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

The aims of this study were to examine prospectively the course of neurological and functional recovery and health related quality of life (HRQoL) in ischaemic stroke patients after intravenous thrombolysis, to assess the 1-year outcome and to determine the early predictors. A group of 53 consecutive patients were assessed at admission to the acute stroke unit (T0), before their discharge (T1), and at 3 (T2) and 12 (T3) months after hospital discharge. The National Institutes of Health Stroke Scale (NIHSS), the Barthel Index (BI) and the Stroke Specific Quality of Life Scale (SSQoL) were used to evaluate stroke severity, functional disability and health related quality of life (HRQoL). A good outcome was defined as simultaneous improvement in all three scales. At T0, 83 % of the patients had severe or moderate neurological impairment. Additionally, 77 % demonstrated very severe or severe disability when assessed by the BI. 74 and 79 % of the patients reported an acceptable HRQoL at 3 and 12 months following discharge, respectively. Neurological and functional status improved significantly over time with most changes occurring during hospitalization and the subsequent 3 months. At T3, 75.5 % of the patients had the good outcome which had been independently predicted by the level of stroke related disability at T0. A majority of the stroke survivors treated with thrombolysis achieved a good outcome. The measurement of stroke specific HRQoL, as a tool for gathering information from the patient, should be incorporated in the assessment of post-stroke recovery and outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ramos-Cabrer P, Campos F, Sobrino T, Castillo J (2011) Targeting the ischaemic penumbra. Stroke 42:7–11

    Article  Google Scholar 

  2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 14:1581–1587

    Google Scholar 

  3. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M et al (1999) Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med 340:1781–1787

    Article  CAS  PubMed  Google Scholar 

  4. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G (2012) Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. The Lancet 379:2364–2372. doi:10.1016/S0140-6736(12)60738-7

    Article  CAS  Google Scholar 

  5. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E et al (2014) Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. The Lancet 384:1929–1935. doi:10.1016/S0140-6736(14)60584-5

    Article  CAS  Google Scholar 

  6. Członkowska A, Kobayashi A (2013) Management of acute stroke-guidelines from the expert group of the section of cerebrovascular diseases of the polish neurological society. Update 2013: thrombolysis. Neurol Neurochir Pol 47:303–309

    PubMed  Google Scholar 

  7. Lahr MM, Luijckx GJ, Vroomen PC, van der Zee DJ, Buskens E (2012) Proportion of patients treated with thrombolysis in a centralized versus a decentralized acute stroke care setting. Stroke 43:1336–1340. doi:10.1161/STROKEAHA.111.641795

    Article  CAS  PubMed  Google Scholar 

  8. Salinas J, Sprinkhuizen SM, Ackerson T, Bernhardt J, Davie C, George MG (2016) An International Standard Set of Patient-Centered Outcome Measures After Stroke. Stroke 47:180–186. doi:10.1161/STROKEAHA.115.010898

    Article  PubMed  Google Scholar 

  9. The American Geriatrics Society Expert Panel on Person-Centered Care (2016) Person-centered care: a definition and essential elements. J Am Geriatr Soc 64:15–18

    Article  Google Scholar 

  10. Schwab-Malek S, Vatankhah B, Bogdahn U, Horn M, Audebert HJ (2010) Depressive symptoms and quality of life after thrombolysis in stroke: the TEMPiS study. J Neurol 257:1848–1854. doi:10.1007/s00415-010-5622-4

    Article  PubMed  Google Scholar 

  11. IST-3 collaborative group (2013) Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial. Lancet Neurol 12:768–776. doi:10.1016/S1474-4422(13)70130-3

    Article  Google Scholar 

  12. de Weerd L, Luijckx GJ, Groenier KH, van der Meer K (2012) Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy. BMC Neurol 26:61–69

    Article  Google Scholar 

  13. Cappellari M, Moretto G, Micheletti N, Donato F, Tomelleri G, Gulli G et al (2014) Off-label thrombolysis versus full adherence to the current European Alteplase license: impact on early clinical outcomes after acute ischemic stroke. J Thromb Thrombolysis 37:549–556. doi:10.1007/s11239-013-0980-2

    Article  PubMed  Google Scholar 

  14. Adams HP, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD (1999) Baseline NIH Stroke Scale score strongly predicts outcome after stroke: a report of the trial of org 10172 in acute stroke treatment (TOAST). Neurology 53:126–131

    Article  CAS  PubMed  Google Scholar 

  15. Anemaet WK (2002) Using standardized measures to meet the challenge of stroke assessment. Top Geriatr Rehabil 18:47–62

    Article  Google Scholar 

  16. Collin C, Wade DT, Davies S, Horne V (1988) The barthel ADL index: a reliability study. Int Disabil Stud 10:61–63

    Article  CAS  PubMed  Google Scholar 

  17. Wade DT, Hewer RL (1987) Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry 50:177–182

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bajer A, Kwolek A (2009) Polska adaptacja skali stroke-specific quality of life. Postępy Rehabil 1: 41–46 (In Polish)

    Google Scholar 

  19. Williams LS, Weinberger M, Harris LE, Clark DO, Biller J (1999) Development of a stroke-specific quality of life scale. Stroke 30:1362–1369

    Article  CAS  PubMed  Google Scholar 

  20. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. The Lancet 22(337):1521–1526

    Article  Google Scholar 

  21. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P et al (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376:112–123. doi:10.1016/S0140-6736(10)60834-3

    Article  PubMed  Google Scholar 

  22. Smith SC, Greenland P, Grundy SM (2000) AHA Conference Proceedings. Prevention conference V: beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association. Circulation 101:111–116

    Article  PubMed  Google Scholar 

  23. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640–1645

    Article  CAS  PubMed  Google Scholar 

  24. Sobolewski P, Śledzińska M, Szczuchniak W, Hatalska-Żerebiec R, Grzesik M, Sobota A (2012) Intravenous thrombolysis patients with acute ischemic stroke: the analysis of the 100 cases. Part I. characteristic of the patients and effectiveness of treatment. Przegl Lek 69:237–241 (Polish)

    PubMed  Google Scholar 

  25. Machumpurath B, Reddy M, Yan B (2013) Rapid neurological recovery post thrombolysis: mechanisms and implications. Neurosci Med 4:36–44. doi:10.4236/nm.2013.41006

    Article  Google Scholar 

  26. Kharitonova T, Mikulik R, Roine RO, Soinne L, Ahmed N, Wahlgren N (2011) Association of early National Institutes of Health Stroke Scale improvement with vessel recanalization and functional outcome after intravenous thrombolysis in ischemic stroke. Stroke 42:1638–1643. doi:10.1161/STROKEAHA.110.606194

    Article  PubMed  Google Scholar 

  27. Yeo LL, Paliwal P, Teoh HL, Seet RC, Chan BP, Wakerley B et al (2013) Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke. J Stroke Cerebrovasc Dis 22:e590–e596. doi:10.1016/j.jstrokecerebrovasdis.2013.07.024

    Article  PubMed  Google Scholar 

  28. Kwakkel G, Kollen B, Twisk J (2006) Impact of time on improvement of outcome after stroke. Stroke 37:2348–2353

    Article  PubMed  Google Scholar 

  29. Nudo RJ (2011) Neural bases of recovery after brain injury. J Commun Disord 44:515–520. doi:10.1016/j.jcomdis.2011.04.004

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hsieh YW, Wang CH, Wu SC, Chen PC, Sheu CF, Hsieh CL (2007) Establishing the minimal clinically important difference of the Barthel Index in stroke patients. Neurorehabil Neural Repair 21:233–238

    Article  PubMed  Google Scholar 

  31. Duncan PW, Lai SM, Keighley J (2000) Defining post-stroke recovery: implications for design and interpretation of drug trials. Neuropharmacology 39:835–841

    Article  CAS  PubMed  Google Scholar 

  32. Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC et al (2016) Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke. A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47:581–641. doi:10.1161/STR.0000000000000086

    Article  PubMed  Google Scholar 

  33. Carod-Artal FJ, Egido JA (2009) Quality of life after stroke: the importance of a good recovery. Cerebrovasc Dis 27:204–214. doi:10.1159/000200461

    Article  PubMed  Google Scholar 

  34. Muus I, Christensen D, Petzold M, Harder I, Johnsen SP, Kirkevold M, Ringsberg KC (2011) Responsiveness and sensitivity of the stroke specific quality of life scale Danish version. Disabil Rehabil 33:2425–2433. doi:10.3109/09638288.2011.573901

    Article  PubMed  Google Scholar 

  35. Mar J, Masjuan J, Oliva-Moreno J, Gonzalez-Rojas N, Becerra V, Casado MÁ et al (2015) Outcomes measured by mortality rates, quality of life and degree of autonomy in the first year in stroke units in Spain. Health Qual Life Outcomes 17:36–44. doi:10.1186/s12955-015-0230-8

    Article  Google Scholar 

  36. Moro CHC, Gonçalves ARR, Longo AL, Fonseca PG, Harger R, Gomes DB et al (2013) Trends of the incidence of ischemic stroke shrombolysis over seven years and one-year outcome: a population-based study in Joinville, Brazil. Cerebrovasc Dis Extra 3:156–166. doi:10.1159/000356984

    Article  PubMed  PubMed Central  Google Scholar 

  37. Pan YT, Lee JD, Lin YH, Huang YC, Weng HH, Lee M et al (2016) Comparisons of outcomes in stroke subtypes after intravenous thrombolysis. SpringerPlus 5:47–52. doi:10.1186/s40064-016-1666-y

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The authors want to thank Prof. Geoffrey Shaw for his linguistic consultation of the paper.

Author information

Authors and Affiliations

  1. Department of Neurological and Psychiatric Nursing, Poznan University of Medical Sciences, Smoluchowski 11 str., 61-170, Poznan, Poland

    Barbara Grabowska-Fudala, Krystyna Jaracz & Krystyna Górna

  2. Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland

    Jan Jaracz

  3. Department of Neurology and Cerebrovascular Disorders, L. Bierkowski Hospital, Poznan University of Medical Sciences, Poznan, Poland

    Radosław Kaźmierski

Authors
  1. Barbara Grabowska-Fudala
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krystyna Jaracz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krystyna Górna
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jan Jaracz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Radosław Kaźmierski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara Grabowska-Fudala.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest concerning this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grabowska-Fudala, B., Jaracz, K., Górna, K. et al. Clinical recovery and health-related quality of life in ischaemic stroke survivors receiving thrombolytic treatment: a 1-year follow-up study. J Thromb Thrombolysis 43, 91–97 (2017). https://doi.org/10.1007/s11239-016-1419-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-016-1419-3

Keywords

Search

Navigation